COLL vs UAL · P/E 17, rev $181.9M vs P/E 10, rev $57.06B
Collegium Pharmaceutical Inc (COLL) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported UAL revenue for 2024-12-31 was $57.06B. Net income was $3.15B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the COLL and UAL stock pages for the full models.
Not investment advice.